Effects of Senegal haplotype ( Xmn1 -rs7412844), alpha-thalassemia (3.7kb HBA1/HBA2 deletion), NPRL3 -rs11248850 and BCL11A -rs4671393 variants on sickle cell nephropathy

Sickle cell anemia (SCA) can cause substantial kidney dysfunction resulting in sickle cell nephropathy, which may be affected by the presence of modifier genes. This study evaluates the effects of some modifier genes on sickle cell nephropathy. Patients living with SCA were recruited. Alpha-thalasse...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of biochemistry and molecular biology 2022, Vol.13 (2), p.5-16
Hauptverfasser: Ndour, El Hadji Malick, Mnika, Khuthala, Guèye Tall, Fatou, Seck, Moussa, Dème Ly, Indou, Nembaware, Victoria, Sagna-Bassène, Hélène Ange Thérèse, Dione, Rokhaya, Ndongo, Aliou Abdoulaye, Diop, Jean Pascal Demba, Barry, Nènè Oumou Kesso, Djité, Moustapha, Ndiaye Diallo, Rokhaya, Guèye, Papa Madièye, Diop, Saliou, Diagne, Ibrahima, Cissé, Aynina, Wonkam, Ambroise, Lopez Sall, Philomène
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Sickle cell anemia (SCA) can cause substantial kidney dysfunction resulting in sickle cell nephropathy, which may be affected by the presence of modifier genes. This study evaluates the effects of some modifier genes on sickle cell nephropathy. Patients living with SCA were recruited. Alpha-thalassemia (3.7kb deletion) was genotyped using gap PCR multiplex. Senegal haplotype (Xmn1-rs7412844), -rs4671393 and -rs11248850 were genotyped using Mass Array. The effects of variants on kidney dysfunction were then evaluated using multivariate analysis. The number of patients living with SCA included in this study was 162 with a median age of 20 years [minimum-maximum: 4-57] and a female frequency of 53.21%. Senegal haplotype, -rs4671393 variant were protective factors against albuminuria stage A2 with an of 0.22 (95% CI 0.05-0.90) and 0.27 (95% CI 0.08-0.96) respectively. The combination -rs11248850 variant - 3.7kb deletion was a protective factor against albuminuria stage A2 ( = 0.087, 95% Cl 0.01-0.78) but it was a risk factor for glomerular hyperfiltration ( = 17.69, 95% CI 1.85-169.31). All four variants displayed a protective effect against albuminuria stage A2. The combination alpha-thalassemia - -rs11248850 variant is a risk factor for glomerular hyperfiltration.
ISSN:2152-4114
2152-4114